Showing results (1731-1740 of 1,853) with videos related to
Sort By:
Pageof 186
Journal of Managed Care & Specialty Pharmacy|July 27, 2019
Evaluation of a Pharmacist-Managed Antidiabetic Deprescribing Program in an Integrated Health Care SystemRita L Hui, Christopher C Chang, Fang Niu, et al.Journal of Managed Care & Specialty Pharmacy|January 27, 2017
Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology ExamplesAndrew P Brogan, Carla DeMuro, Amy M Barrett, et al.Journal of Managed Care & Specialty Pharmacy|January 27, 2017
Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected CountriesYuting Zhang, Hana Chantel Hueser, Inmaculada HernandezJournal of Managed Care & Specialty Pharmacy|January 27, 2017
Health Care Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia with Better Adherence to Tyrosine Kinase Inhibitors and Increased Molecular Monitoring FrequencyDominick Latremouille-Viau, Annie Guerin, Patrick Gagnon-Sanschagrin, et al.Journal of Managed Care & Specialty Pharmacy|March 8, 2019
Budget Impact of a Steroid-Eluting Sinus Implant Versus Sinus Surgery for Adult Chronic Sinusitis Patients with Nasal PolypsFrank R Ernst, Ryan J Imhoff, Adam DeConde, et al.Journal of Managed Care & Specialty Pharmacy|May 27, 2015
Health care resource utilization and costs associated with nonfatal major adverse cardiovascular eventsJennifer S Korsnes, Keith L Davis, Rinat Ariely, et al.Journal of Managed Care & Specialty Pharmacy|February 10, 2026
Challenges of the Inflation Reduction Act for long-term care pharmacy: Examining impact and policy solutionsShiven Bhardwaj, Howard Weston Schmutz, Jonathan H Watanabe, et al.Journal of Managed Care & Specialty Pharmacy|February 4, 2026
AMCP Market Insights: The role of managed care in improving patient care in mucopolysaccharidosesBridget Flavin, Ryan Haumschild, Terri K Klein, et al.Journal of Managed Care & Specialty Pharmacy|February 4, 2026
Patient factors and costs associated with prophylactic neurokinin-1 receptor antagonist use among women with invasive breast cancerShweta Kamat, Britny R Brown, Steven A Cohen, et al.Journal of Managed Care & Specialty Pharmacy|January 27, 2023
Real-world impact of empagliflozin on total cost of care in adults with type 2 diabetes: Results from an outcomes-based agreementSamuel K Peasah, Yan Huang, Swetha R Palli, et al.Pageof 186